
    
      The study aims to investigate the role of candidate biomarkers in the diagnosis and prognosis
      of AA and AD. In the diagnosis part, we begin with a discovery phase where individually
      matched case-control study. Patients within each disease outcomes (i.e. AD, AMI, PE, AA
      without AD and healthy controls) are age and sex matched and retrospectively included.In the
      prognosis part of the study, patients with confirmed AA and AD are enrolled. The primary
      outcome is the all-cause mortality based on the death certificates. The secondary outcome is
      the in-hospital mortality according to the patients'medical records.
    
  